...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Financials
1
Aug 07, 2019 05:15PM
2
Aug 09, 2019 10:26AM

"Last year it reported quarterly. It is not following suit this year."

For the past few years, the MD&A has been filed on SEDAR mid- to late-month in March, August, September and December. Not sure why they file in this pattern, but so far this year's pattern is no different than the past few years. If the pattern continues, next MD&A will be mid- to late- August 2019. 

BDAZ 

6
Aug 09, 2019 11:26AM
2
Aug 09, 2019 11:57AM
4
Aug 09, 2019 12:17PM
Share
New Message
Please login to post a reply